Muthurania Kevin, Ignatius Arun Alphonse, Jin Zhaowei, Williams Jennifer, Ohtake Satoshi
Pharmaceutical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc. Chesterfield Missouri 63017.
Pharmaceutical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc. Chesterfield Missouri 63017.
J Pharm Sci. 2015 Nov;104(11):3770-3781. doi: 10.1002/jps.24584. Epub 2015 Jul 23.
Evaluation of the physical characteristics of vaccines formulated in the presence of adjuvants, such as aluminum salts (Alum), is an important step in the development of vaccines. Depending on the formulation conditions and the associated electrostatic interactions of the adjuvant particles, the vaccine suspension may transition between flocculated and deflocculated states. The impact of practical formulation parameters, including pH, ionic strength, and the presence of model antigens, has been correlated to the sedimentation behavior of aluminum phosphate suspensions. A novel approach for the characterization of suspension properties of Alum has been developed to predict the flocculated state of the system using a sedimentation analysis-based tool (Turbiscan®). Two sedimentation parameters, the settling onset time (Sonset) and the sedimentation volume ratio (SVR) can be determined simultaneously in a single measurement. The results demonstrate the suspension characteristics to be significantly altered by solution conditions (pH and ionic strength) and the charge state of bound antigens. Formulation conditions that promote the flocculated state of the suspension are characterized by faster Sonset and higher SVR, and are generally easy to resuspend. The Turbiscan® method described herein is a useful tool for the characterization of aluminum-containing suspensions and may be adapted for screening and optimization of suspension-based vaccine formulations in general.
评估在佐剂(如铝盐(明矾))存在下配制的疫苗的物理特性是疫苗开发中的重要一步。根据配制条件和佐剂颗粒相关的静电相互作用,疫苗悬浮液可能在絮凝和非絮凝状态之间转变。实际配制参数(包括pH值、离子强度和模型抗原的存在)的影响已与磷酸铝悬浮液的沉降行为相关联。已开发出一种用于表征明矾悬浮特性的新方法,以使用基于沉降分析的工具(Turbiscan®)预测系统的絮凝状态。在单次测量中可同时测定两个沉降参数,即沉降起始时间(Sonset)和沉降体积比(SVR)。结果表明,悬浮特性会因溶液条件(pH值和离子强度)以及结合抗原的电荷状态而发生显著变化。促进悬浮液絮凝状态的配制条件的特征是沉降起始时间更快和沉降体积比更高,并且通常易于重新悬浮。本文所述的Turbiscan®方法是表征含铝悬浮液的有用工具,并且通常可适用于基于悬浮液的疫苗制剂的筛选和优化。